Novozymes A/S (OTCMKTS:NVZMY) Issues Earnings Results, Misses Estimates By $0.26 EPS

Novozymes A/S (OTCMKTS:NVZMY) issued its quarterly earnings data on Thursday. The biotechnology company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.26), Zacks reports. Novozymes A/S had a net margin of 14.70% and a return on equity of 6.54%.

Novozymes A/S Price Performance

Shares of OTCMKTS NVZMY traded up $2.87 during midday trading on Thursday, reaching $71.52. 57,923 shares of the company were exchanged, compared to its average volume of 24,698. The stock’s 50-day moving average price is $67.55 and its 200-day moving average price is $62.64. The stock has a market cap of $29.65 billion, a P/E ratio of 38.57, a PEG ratio of 3.08 and a beta of 0.86. The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 0.25. Novozymes A/S has a one year low of $49.90 and a one year high of $75.27.

Novozymes A/S Company Profile

Novozymes A/S was a Denmark-based biotechnology company that developed and commercialized enzymes, microorganisms and other biological solutions for industrial and consumer applications. Its products were designed to help customers improve manufacturing processes, reduce resource consumption and develop more sustainable alternatives to conventional chemicals and production methods.

The company served a broad range of industries, including food and beverages, household care, agriculture, animal health, bioenergy and industrial manufacturing.